# 2026-22725: Commerce Asks How Specialty Medicine Imports Affect National Security

2026-22725, Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Section 232 National Security Adjustments to Imports of Specialty Pharmaceuticals and Associated Ingredients, is a Federal Register notice from Commerce Department, Industry and Security Bureau published 2026-11-06, effective Comments regarding this proposed information collection must be received on or before January 5, 2027.; PRIA reads it as touching household money (as of 2026-11-06).

- Canonical: https://policyrisk.com/federal-register/2026-22725
- As of: 2026-11-06
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22725
- Title: Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Section 232 National Security Adjustments to Imports of Specialty Pharmaceuticals and Associated Ingredients
- Type: Notice
- Agencies: Commerce Department; Industry and Security Bureau
- Citation: 91 FR 70045
- Published: 2026-11-06
- Effective: Comments regarding this proposed information collection must be received on or before January 5, 2027.
- Comments close: 2027-01-05
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-06

## In one line

Commerce Asks How Specialty Medicine Imports Affect National Security

## Summary

The Department of Commerce is asking for public feedback on a new rule that adjusts imports of specialty medicines and their ingredients to protect U.S. national security. This affects companies importing these products and aims to keep important medicines safe and available. Comments are open until January 5, 2027, and the rule could change how imports are managed, possibly impacting costs and supply chains.

## Abstract

The Department of Commerce, in accordance with the Paperwork Reduction Act of 1995 (PRA), invites the general public and other Federal agencies to comment on proposed, and continuing information collections, which helps us assess the impact of our information collection requirements and minimize the public's reporting burden. The purpose of this notice is to allow for 60 days of public comment on the OMB approved emergency collection for the Temporary Final Rule "Section 232 National Security Adjustments to Imports of Specialty Pharmaceuticals and Associated Ingredients" September 23, 2026, (91 FR 60360).

## Effects PRIA read

- Importers Must Submit Urgent Health Need Requests: cost, low. If you import specialty pharmaceutical products and want the zero percent tariff for items that meet an urgent health need, you must submit an "Urgent Health Need Request" to Commerce by email that includes organization information, HTSUS classification, country of origin, importer of record, a det…
- Presidential Proclamation Imposes Tariffs: cost, medium. On April 2, 2026, Presidential Proclamation 11020 imposed ad valorem tariffs on imports of certain patented pharmaceuticals and associated pharmaceutical ingredients. This action affects companies importing those covered products.
- Zero-Percent Tariff for Designated Specialty Drugs: benefit, medium. Certain designated specialty pharmaceutical products and their associated ingredients may receive a tariff rate of zero percent if Commerce (in consultation with the U.S. Trade Representative and HHS) determines the products are from a jurisdiction with a current or forthcoming trade and security f…

## Related documents

- [2026-22726](https://policyrisk.com/federal-register/2026-22726): Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request;…, 2026-11-06
- [2026-21840](https://policyrisk.com/federal-register/2026-21840): Order Renewing Order Temporarily Denying Export Privileges, 2026-10-27
- [2026-20938](https://policyrisk.com/federal-register/2026-20938): Guidance to U.S. Customs and Border Protection Regarding the Assessment of “U.S. Content” for Purposes of Implementing Tariffs Pursuant to…, 2026-10-14
- [2026-20058](https://policyrisk.com/federal-register/2026-20058): Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request;…, 2026-09-30
- [2026-19927](https://policyrisk.com/federal-register/2026-19927): URAL Airlines JSC, Utrenniy Lane 1-g, Yekaterinburg, Russia 620025; Order Renewing Temporary Denial of Export Privileges, 2026-09-29
- [2026-19537](https://policyrisk.com/federal-register/2026-19537): Measures To Restrict Stockpiling of Polysilicon and Polysilicon Derivatives Under Proclamation 11052, 2026-09-24

## Sources
- [2026-22725 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/06/2026-22725/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-omb-for)
- [2026-22725 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-06/pdf/2026-22725.pdf)

## Related
- [Previous: 2026-22724, Records Governing Off-the-Record Communications; Public Notice](https://policyrisk.com/federal-register/2026-22724)
- [Next: 2026-22726, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2026-22726)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22725 (as of 2026-11-06).